Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05212428 · ClinicalTrials.gov registry record · NA
DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study
A NA study of Genetic Disorder, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 110,000
- Enrollment target
- 3
- Study locations
NCT05212428 is a NA study of Genetic Disorder that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 110,000 participants, above the 198-participant average among 5 other Genetic Disorder trials with a reported enrollment target (55456% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT05212428, a NA study of Genetic Disorder, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 110,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial collects information on how sequencing a patient's deoxyribonucleic acid (DNA) (i.e., the genetic material) could impact their health care. This study also develops and improves ways to include genomic information from DNA sequencing into the electronic health record to create a more complete "Health Tapestry" for each participant. Sequencing of a patient's DNA leads to the detection of genetic variants some of which determine risk for disease development. Discovery of those genetic variants in a patient could result in prevention, earlier diagnosis or better therapy of disease.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Questionnaire Administration
- OTHER Diagnostic Laboratory Biomarker Analysis
- OTHER Genetic Counseling
Study Locations (3)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110,000 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05212428
The ClinicalTrials.gov registry entry for NCT05212428 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 110,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 198-participant average among 5 other Genetic Disorder trials with a reported enrollment target (55456% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Genetic Disorder appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT05212428 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05212428 about?
NCT05212428 is a clinical study titled "DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study". This clinical trial collects information on how sequencing a patient's deoxyribonucleic acid (DNA) (i.e., the genetic material) could impact their health care. This study also develops and improves ways to include genomic information from DNA sequencing into the electronic health record to create a ...
What is the current status of trial NCT05212428?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 110,000 participants. The study started on 2020-01-22. Estimated completion is 2026-12-31.
What conditions does trial NCT05212428 study?
This clinical trial studies the following conditions: Genetic Disorder.
What interventions are being tested in trial NCT05212428?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER), Diagnostic Laboratory Biomarker Analysis (OTHER), Genetic Counseling (OTHER).
Who is sponsoring clinical trial NCT05212428?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05212428 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Inherited Reproductive Disorders
RECRUITING
-
Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes
ACTIVE NOT RECRUITING
-
Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy
ACTIVE NOT RECRUITING
-
Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
COMPLETED · Phase 1
-
Pediatric Patients With Metabolic or Other Genetic Disorders
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.